Page 25 - JCTR-10-3
P. 25
Shegena et al. | Journal of Clinical and Translational Research 2024; 10(3): 191-200 199
[11] Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Related Problems and Health Outcomes: A Cross-
Practice: The Patient-centered Approach to Medication Sectional Study among Cardiovascular Patients. Pharm
Management. New York: McGraw Hill Professional; World Sci 2010;32:512-9.
2012. doi: 10.1007/s11096-010-9401-1
[12] Pharmaceutical Care Network Europe. Classification [23] Basger BJ, Moles RJ, Chen TF. Development of an
for Drug Related Problems Version 9.1. Netherlands: Aggregated System for Classifying Causes of Drug-
Pharmaceutical Care Network Europe Association; 2020. Related Problems. Ann Pharmacother 2015;49:405-18.
p. 1-10. Available from: https://www.pcne.org/upload/ doi: 10.1177/1060028014568008
files/334_pcne_classification_v9-0.pdf [Last accessed [24] Maggioni AP. Epidemiology of Heart Failure in Europe.
on 2022 Jun 11]. Heart Fail Clin 2015;11:625-35.
[13] Hohmann C, Eickhoff C, Klotz JM, Schulz M, doi: 10.1016/j.hfc.2015.07.015
Radziwill R. Development of a Classification System for
Drug-Related Problems in the Hospital Setting (APS- [25] Wendie TF, Angamo MT. Drug-Therapy Problems and
Doc) and Assessment of the Inter-Rater Reliability. Predictors among Hospitalized Heart-Failure Patients:
J Clin Pharm Ther 2012;37:276-81. A Prospective Observational Study. Drug Healthc Patient
Saf 2020;12:281-91.
[14] Flesch M, Erdmann E. The Problem of Polypharmacy in doi: 10.2147/DHPS.S268923
Heart Failure. Curr Cardiol Rep 2006;8(3):217-25.
[15] Viktil KK, Blix HS. The Impact of Clinical Pharmacists [26] WHO. World Health Organisation. WHO Collaborating
on Drug-Related Problems and Clinical Outcomes. Basic Centre for Drug Statistics Methodology; 2022. Available
Clin Pharmacol Toxicol 2008;102:275-80. from: https://www.whocc.no/atc_ddd_index [Last
accessed on 2021 May 18].
doi: 10.1111/j.1742-7843.2007.00206.x [27] Niriayo YL, Kumela K, Kassa TD, Angamo MT.
[16] Yadesa TM, Kitutu FE, Deyno S, Ogwang PE, Drug Therapy Problems and Contributing Factors in
Tamukong R, Alele PE. Prevalence, Characteristics the Management of Heart Failure Patients in Jimma
and Predicting Risk Factors of Adverse Drug Reactions University Specialized Hospital, Southwest Ethiopia.
among Hospitalized Older Adults: A Systematic PLoS One 2018;13:e0206120.
Review and Meta-analysis. SAGE Open Med doi: 10.1371/journal.pone.0206120
2021;9:20503121211039099.
doi:10.1177/20503121211039099 [28] Gizaw K, Dubale M. Drug Related Problems and
Contributing Factors among adult Ambulatory Patients
[17] Sztramko R, Chau V, Wong R. Adverse Drug Events and with Cardiovascular Diseases at Gebretsadik Shawo
Associated Factors in Heart Failure Therapy among the General Hospital, Bonga, South West Ethiopia. J Nat Sci
Very Elderly. Can Geriatr J 2011;14:79-92. Res 2017;7:9-16.
doi: 10.5770/cgj.v14i4.19 [29] Seid E, Engidawork E, Alebachew M, Mekonnen D,
[18] Rushton CA, Strömberg A, Jaarsma T, Kadam UT. Berha AB. Evaluation of Drug Therapy Problems,
Multidrug and Optimal Heart Failure Therapy Prescribing Medication Adherence and Treatment Satisfaction
in Older General Practice Populations: A Clinical Data among Heart Failure Patients on Follow-up at a Tertiary
Linkage Study. BMJ Open 2014;4:e003698. Care Hospital in Ethiopia. PLoS One 2020;15:e0237781.
doi: 10.1136/bmjopen-2013-003698 doi: 10.1371/journal.pone.0237781
[19] Urbina O, Ferrández O, Luque S, Grau S, Mojal S, [30] Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L,
Pellicer R, et al. Patient Risk Factors for Developing a Mangues MA, Bayes-Genis A. Negative Clinical
Drug-related Problem in a Cardiology Ward. Ther Clin Outcomes Associated with Drug-related Problems in Heart
Risk Manag 2015;11:9-15. Failure (HF) Outpatients: Impact of a Pharmacist in a
doi: 10.2147/TCRM.S71749 Multidisciplinary HF Clinic. J Card Fail 2011;17:217-23.
[20] Tegegne GT, Yimamm B, Yesuf EA. Drug Therapy doi: 10.1016/j.cardfail.2010.10.009
Problems and Contributing Factors among Patients with [31] Hsu WT, Shen LJ, Lee CM. Drug-Related Problems
Cardiovascular Diseases in Felege Hiwot Referral and Vary with Medication Category and Treatment Duration
Jimma University Specialized Hospital, Ethiopia. Indo in Taiwanese Heart Failure Outpatients Receiving Case
Glob J Pharm Sci 2015;5:26-39. Management. J Formos Med Assoc 2016;115:335-42.
doi: 10.35652/igjps.2015.21 doi: 10.1016/j.jfma.2015.11.014
[21] Shareef J, Sandeep B, Shastry CS. Assessment of Drug [32] Shwetha N, Pradhan A, Shabaraya AR, Niveditha TV,
Related Problems in Patients with Cardiovascular Jose C, Ambika V. Risk Factors for Developing Drug
Diseases in a Tertiary Care Teaching Hospital. J Pharm Related Problems in Patients with Cardiovascular
Care 2014;2:70-6. Diseases. Int J Res Rev 2021;8:403-9.
[22] Niquille A, Bugnon O. Relationship between Drug- [33] Tegegne GT, Yimam B, Yesuf EA, Gelaw BK,
DOI: https://doi.org/10.36922/jctr.23.00137

